Chronic Kidney Disease Market Report
First published: 11 October 2024 | Last updated: 25 May 2026 | Report Code: chronic-kidney-disease
Chronic Kidney Disease Market — USD 12.3 billion in 2023, Growing to USD 23.94B by 2033 at 6.7% CAGR
This report provides a comprehensive analysis of the Chronic Kidney Disease market, covering size, CAGR, regional insights, industry trends, and forecasts for the years 2023 to 2033.
Key Takeaways
- Global market expands from $12.30 Billion in 2023 to $23.94 Billion in 2033 at a 6.7% CAGR.
- North America is largest regional market, while no single fastest-growing region is stated because regional CAGR differences remain within 0.15 percentage points.
- Regional markets show steady increases across Europe, Asia Pacific, Latin America, and Middle East & Africa.
- Treatment segments such as dialysis, kidney transplantation and medications remain central to market structure.
- Major vendors include Fresenius Medical Care, DaVita Inc., B. Braun Melsungen AG, and Abbott Laboratories.
Chronic Kidney Disease Market Report — Executive Summary
North America remains largest market by forecast-period value, while no single fastest-growing region is stated because top regional growth rates are separated by less than 0.15 percentage points. The Chronic Kidney Disease market is driven by demographic shifts, growing chronic disease prevalence, and improvements in diagnostic and therapeutic technologies. Increasing incidences of diabetes and hypertension, aging populations, and broader awareness support demand for dialysis, transplantation, and pharmaceutical management. The market structure includes treatment types, end users, and regional markets, with hospitals, clinics and home healthcare settings factoring into uptake. Key participants such as Fresenius Medical Care, DaVita Inc., B. Braun Melsungen AG, and Abbott Laboratories shape product availability and service delivery. Ongoing advances in remote monitoring, home-based dialysis, and personalized therapeutic approaches are influencing care models and investment priorities. Challenges include treatment costs and infrastructure gaps in some regions, but regulatory emphasis on value-based care and preventive measures supports longer-term market expansion. The report combines primary industry interviews and secondary literature to present validated trends and strategic implications for stakeholders.
Key Growth Drivers
- Rising prevalence of diabetes and hypertension increasing demand for CKD diagnosis and treatment.
- Aging populations in multiple regions contributing to higher incidence of chronic renal conditions.
- Technological progress in dialysis systems, transplant procedures, and pharmaceuticals improving treatment options.
- Growing adoption of home healthcare and remote monitoring that expands access to maintenance therapies.
- Policy shifts toward value-based care encouraging preventive programs and integrated disease management.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $12.30 Billion |
| CAGR (2023-2033) | 6.7% |
| 2033 Market Size | $23.94 Billion |
| Top Companies | Fresenius Medical Care, DaVita Inc., B. Braun Melsungen AG, Abbott Laboratories |
| Published Date | 11 October 2024 |
| Last Modified Date | 25 May 2026 |
Chronic Kidney Disease Market Overview
Customize Chronic Kidney Disease Market Report market research report
- ✔ Get in-depth analysis of Chronic Kidney Disease market size, growth, and forecasts.
- ✔ Understand Chronic Kidney Disease's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Chronic Kidney Disease
What is the Market Size & CAGR of Chronic Kidney Disease Market Report market in 2023?
Chronic Kidney Disease Industry Analysis
Chronic Kidney Disease Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Chronic Kidney Disease Market Report Market Analysis Report by Region
Europe Chronic Kidney Disease Market Report:
Europe grows from $3.29 Billion in 2023 to $6.4 Billion in 2033. Market development is supported by aging demographics, increasing chronic disease management programs, and greater access to pharmaceutical and dialysis therapies across national health systems.Asia Pacific Chronic Kidney Disease Market Report:
Asia Pacific grows from $2.38 Billion in 2023 to $4.64 Billion in 2033. Growth drivers include rising incidence of diabetes and hypertension, expanding healthcare access, and gradual uptake of advanced treatment modalities and home-based care.North America Chronic Kidney Disease Market Report:
North America is largest regional market, rising from $4.6 Billion in 2023 to $8.95 Billion in 2033. Expansion reflects established clinical infrastructures, high utilization of dialysis and transplantation services, and adoption of advanced treatment technologies and home-care solutions.South America Chronic Kidney Disease Market Report:
Latin America grows from $0.54 Billion in 2023 to $1.04 Billion in 2033. The region’s market movement is influenced by improving diagnostic reach, growing awareness of kidney health, and incremental investment in renal care infrastructure.Middle East & Africa Chronic Kidney Disease Market Report:
Middle East and Africa grows from $1.5 Billion in 2023 to $2.91 Billion in 2033. Demand is shaped by increasing chronic disease prevalence, efforts to strengthen healthcare infrastructure, and adoption of treatment options including dialysis and transplantation.Tell us your focus area and get a customized research report.
Research Methodology
Chronic Kidney Disease Market Analysis By Type
The Chronic Kidney Disease market by type includes stages of CKD, notably highlighting that Stage 1 to 5 covers a market size of $10.16 billion in 2023, projected to reach $19.77 billion in 2033, maintaining a market share of 82.58%. This emphasizes the importance of stage-specific treatment options and management strategies.
Chronic Kidney Disease Market Analysis By Treatment
In terms of treatment, dialysis leads with a 65.31% market share in 2023, size at $8.03 billion growing to $15.63 billion in 2033. Kidney transplantation and medications also present significant opportunities, with sizes growing from $2.50 to $4.87 billion and $1.76 to $3.43 billion, respectively, showcasing evolving treatment landscapes.
Chronic Kidney Disease Market Analysis By End User
The market segmentation by end-users demonstrates that hospitals, clinics, and home healthcare are pivotal in CKD management. Hospitals hold a commanding share, with revenues of $8.03 billion in 2023, growing to $15.63 billion by 2033. The segment illustrates a progressive shift towards outpatient and home healthcare settings, reflecting changing patient preferences.
Chronic Kidney Disease Market Analysis By Region
The regional market analysis indicates diverse growth patterns across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa, affected by factors such as healthcare infrastructure, disease management policies, and patient demographic shifts. Tailoring strategies to region-specific needs can enhance growth prospects.
Chronic Kidney Disease Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Chronic Kidney Disease Industry
Fresenius Medical Care:
A global leader in renal care, providing products and services for individuals with chronic kidney failure and focusing on innovations in dialysis treatment.DaVita Inc.:
A leading provider of kidney care services globally, emphasizing a personalized approach to treatment for chronic kidney disease patients.B. Braun Melsungen AG:
Specializes in manufacturing medical supplies and pharmaceuticals for CKD treatment and offers innovative dialysis solutions.Abbott Laboratories:
Offers critical diagnostics and therapeutic solutions for kidney disease, aiming for improved patient quality of care.We're grateful to work with incredible clients.
FAQs
What is the market size of the Chronic Kidney Disease Market Report in 2023?
The market size was $12.30 Billion in 2023, reflecting current demand across treatment and care delivery segments including dialysis, transplantation and medications.
How big is the Chronic Kidney Disease Market Report expected to be in 2033?
By 2033 the market is projected to reach $23.94 Billion, driven by increased patient populations and expanded treatment and care solutions across settings.
What is CAGR of the Chronic Kidney Disease Market Report for 2023 to 2033?
The compound annual growth rate for the forecast period 2023 to 2033 is 6.7%, indicating steady expansion across therapies and regional markets.
Who are the key companies in the Chronic Kidney Disease market?
Top companies listed include Fresenius Medical Care, DaVita Inc., B. Braun Melsungen AG, and Abbott Laboratories as principal market participants.
Is there a single fastest Growing region in the Chronic Kidney Disease Market Report market?
No single fastest-growing region is stated for the Chronic Kidney Disease Market Report market because the top regional implied CAGR values are within 0.15 percentage points of each other, making the ranking too close to call reliably.
Which treatment types are included in the market segmentation?
Treatment categories cover dialysis, kidney transplantation and medications, representing core therapeutic approaches across acute and maintenance care settings.
What end users are covered in the market analysis?
End-user segments encompass hospitals, clinics and home healthcare, each playing a role in delivery of dialysis, transplantation follow-up and medication management.
How was the market research conducted?
The study utilized primary interviews with industry specialists and secondary analysis of company reports and publications, combined with internal validation and triangulation.